“showed a trend”

The meta-analysis based on 18 comparisons showed a trend ( p = 0.057) toward increased final body weight (FBW) in lambs receiving malic acid supplementation.

Our cohort exhibited slow latencies, and our younger participants showed a trend of utilizing this compensation by increasing their strength responses compared with control data ( p = 0.057, with a medium effect size).

Of the above genera identified as differentially abundant by Corncob, only Neisseria showed a trend ( P = 0.057) in Statin+ users by MaAsLin2 and no genera were identified using both ALDEx2 and ANCOM-II ( S5 Table ).

Interaction between GROUP and GVS was not significant (p = 0.674), neither was GROUP × VS ( p = 0.75), the three-way interaction GROUP × GVS × VS showed a trend ( F (6, 312) = 2.06, p = 0.057, η 2 = 0.008, Fig. 5 B).

In contrast, in vitro stimulation of MNCs from PEDV-inoculated pigs significantly enhanced PEDV-specific IgA antibody secretion from MLNs at 28 dpi and the ileum at 7 dpi, and showed a trend towards enhancing secretion from the ileum at 28 dpi (p = 0.057), compared to no stimulation (Figure 4 ).

However, hair cortisol showed a trend for a negative association with childhood life events in patients ( β = −.163, p = .057), but not in controls ( β = .085, p = .515). 5.3 Hair cortisol and brain volumes When using a transdiagnostic approach, hair cortisol level was not related to any lobe volume (lowest p = .313) or cortical thickness per lobe (lowest p = .231) (Supplementary Table 3 ). 5.4 Moderation by diagnosis The association of CA with cortical thickness were moderated by diagnosis in the temporal lobe ( p = .039) and occipital lobe ( p = .016) (Supplementary Table 4 ).

Patients with post-MRD + showed a trend of higher NRM than those with post-MRD − (5.2% vs . 15.5%, P = 0.057) in the univariate analysis, but there was no significance in the multivariate analysis.

The difference between P3 and P4 showed a trend for a difference in TRP in the alpha band ( p = 0.057).

Clinical results At day two following treatment, ketamine significantly improved MADRS scores (mean difference -6.5 [95% CI -10.6 to -2.5]; paired t -test, p = 0.003), TEPS-anticipatory scores (mean difference 6.8 [95% CI 2.9 to 9.5]; paired t -test, p = 0.038), TEPS-consummatory scores (mean difference 5.6 [95% CI 1.8 to 6.1]; paired t -test, p = 0.018) and showed a trend to improve SHAPS scores (mean difference -5.2 [95% CI -10.7 to 0.2]; paired t -test, p = 0.057) compared to placebo (Supplementary Fig.

The MTJ surface area, normalised to total surface area, showed a trend towards an age-related increase (p = 0.0571; Fig. 1 d), suggesting enlargement of the MTJ with ageing.

27%; p = 0.0001) and showed a trend toward a higher rate of complete occlusion ( p = 0.0571).

The Mayo score AUC of vedolizumab treatment showed a trend of decreased colitis ( p = 0.0571) compared to control treatment.

( P -value = 0.0286), whereas Gap43 showed a trend of downregulation at peak ( P -value = 0.0571), a further indicator for axonal damage.

The quantification of mtDNA copies also showed a trend for lower values in these cells despite no statistical significance (nCTR2 vs. nHD2; p = 0.0571) (Figure 1e ).

The combined nilotinib + artesunate treatment reduced brain edema ( P = .01) and showed a trend toward reduced lung edema that did not achieve statistical significance ( P = .0572; Figure 6 H-I).

The SCZ PRS including all SNPs ( P -value threshold P < 1) showed a trend towards association in the ADHD/ASD sample (OR 1.13, P = 5.72 × 10 −2 ) (Supplementary Tables S2 and S3 and Figs.

The functional enrichment analysis showed a trend to enrichment for chemokine signalling ( p = 0.0573, FDR = 0.0749), synaptic vesicle cycle ( p = 0.0636, FDR = 0.0749), GABAergic synapse ( p = 0.0738, FDR = 0.0749), and cholinergic synapse ( p = 0.0745, FDR = 0.0749) pathways ( Figure 4 , Supplementary Tables S9 and S10 ).

Results: Post-matching, PFS-INV was improved significantly for zanubrutinib versus acalabrutinib (hazard ratio (HR) = 0.68 (95% confidence interval (CI): 0.46–0.99); p = 0.0448) and OS showed a trend toward improvement for zanubrutinib (HR = 0.60; 95% CI: 0.35–1.02, p = 0.0575).

Finally, viral load in patients with EBERs+/IgD+ cells showed a trend to higher values (p = 0.0576, Mann Whitney test).

While for patients after surgical resection, patient with P/LP GVs showed a trend towards a longer OS (HR = 0.7340, 95% CI: 0.5335–1.0100, p = 0.0576, see Fig. 5 F) and RFS (HR = 0.8297, 95% CI: 0.6274–1.0971, p = 0.1903, see Fig. 5 G) compared to patients without P/LP GVs.

Lastly, In the Highly and Moderately differentiated group, MTV showed a trend toward negative association with HER2 positivity (β=-0.1345, P=0.0576), whereas TLG had no predictive value (P=0.5853).For Low polarization tumors, neither MTV nor TLG reached statistical significance (both P>0.25), likely due to limited sample size (n=23) ( Table 5 ). 4.

WBISI (2.8 ± 1.9) showed a trend towards improvement in Rx group (p = 0.0577) after adjustment for covariates.

1 A), and they both showed a trend towards an increase in HCM_Aged mice hearts (1.5-fold p = 0.0577 for miR-146b, 1.4-fold p = 0.1303 for miR-142-3p) ( Fig. 1 B).

The root diameters showed a trend toward positive correlation with disease duration in anti-NF155 antibody-positive CIDP patients ( r = 0.739, P = 0.0578, Fig. 2 D), but not in anti-NF155 antibody-negative patients (data not shown).

MDR1/3435(C > T), which was in Hardy–Weinberg equilibrium, showed a trend of association with PFS ( p = 0.0578), response rate ( p = 0.0782) and TTP ( p = 0.0923) in PLD + bortezomib patients, though no correlation was found in the bortezomib arm.